Table 5 The postoperative facial numbness (BNI I-IV) in follow up
Discharge | 1 month | 3 months | 6 months | 12 months | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
RFT (n = 97) | Coblation (n = 150) | RFT (n = 97) | Coblation (n = 150) | RFT (n = 97) | Coblation (n = 150) | RFT (n = 97) | Coblation (n = 150) | RFT (n = 97) | Coblation (n = 150) | |
I, n (%) | 8 (8.2%) | 18 (12%) | 9 (9.3%) | 20 (13.3%) | 12 (12.4%) | 29 (19.3%) | 15 (15.5%) | 40 (26.7%) | 19 (19.6%) | 52 (34.7%) |
II, n (%) | 23 (23.7%) | 54 (36%) | 25 (25.8%) | 54 (36%) | 34 (35.1%) | 59 (39.3%) | 41 (42.3%) | 71 (47.3%) | 42 (43.3%) | 64 (42.7%) |
III, n (%) | 59 (60.8%) | 76 (50.7%) | 59 (60.8%) | 73 (48.7%) | 48 (49.5%) | 59 (39.3%) | 38 (39.2%) | 37 (24.7%) | 32 (35.1%) | 32 (21.3%) |
IV, n (%) | 7 (7.2%) | 2 (1.3%) | 4 (4.1%) | 3 (2.0%) | 3 (3.1%) | 3 (2.0%) | 3 (3.1%) | 2 (1.3%) | 2 (2.1%) | 2 (1.3%) |
Mean-Rank | 138.07 | 114.9 | 135.38 | 116.64 | 134.04 | 117.51 | 139.35 | 114.08 | 139.80 | 113.78 |
Median | III | III | III | III | III | II | II | II | II | II |
Wilcoxon W | 17,235.0 | 17,496.5 | 17,626.5 | 17,111.5 | 17,067.0 | |||||
P | 0.006* | 0.026* | 0.056 | 0.004* | 0.003* | |||||